Crinecerfont (NBI-74788), a Novel CRF₁ Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia

DOWNLOAD PDF INGREZZA® (valbenazine) capsules or INGREZZA® SPRINKLE (valbenazine) capsules Prescribing Information

Need to get in touch with us?

medinfo@neurocrine.com
1-877-641-3461